|Bid||0.00 x 1200|
|Ask||0.00 x 1000|
|Day's Range||281.30 - 286.30|
|52 Week Range||226.02 - 287.59|
|Beta (3Y Monthly)||1.22|
|PE Ratio (TTM)||196.62|
|Earnings Date||Feb 21, 2019|
|Forward Dividend & Yield||1.36 (0.48%)|
|1y Target Est||299.82|
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Favorable Coverage Decisions Broaden Access to This Minimally Invasive Treatment That Provides Rapid Relief and Recovery from Symptoms
Teleflex Inc NYSE:TFXView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for TFX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding TFX totaled $942 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
NEW YORK, Feb. 08, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Teleflex Incorporated (TFX), a leading global provider of medical technologies for critical care and surgery, has announced that it received premarket approval (PMA) from the U.S. Food and Drug Administration for the MANTA™ Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure. The MANTA™ Vascular Closure Device is indicated for closure of femoral arterial access sites while reducing time to hemostasis following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures.
After trading at a "double bottom" at around $230, Teleflex Inc. (NYSE:TFX) attracted more buying activity after presenting at the JPMorgan Chase (NYSE:JPM) health care conference in early January. The firm has a strong, steady business in selling supplies to emergency care facilities. And while the TFX stock price reflects the growth expectations after closing at ~$260, investors should look at this medical instruments provider. Teleflex generated sales of $2.15 billion in FY 2017. In Q3/2018, revenue grew by 5.6% in a period that is usually seasonally weak. Teleflex forecast Q4 performance and estimated it will grow 5%-5.5% for the full-year 2018. Management is on track with its business growth plan. Its acquisition of UroLift brought in $49 million in revenue, up 45% year-on-year. The prostate treatment unit accomplished growth despite supply issues during the second quarter. Adjusted gross and operating margins was 57% and 26%, respectively. For the year, Teleflex believes EPS will come in at between $9.80 to $9.95. This values TFX stock at a 26 times forward earnings. InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks at Risk of the Global Smartphone Slowdown Teleflex is expected to report fourth-quarter earnings on January 31 before market open. ### Growth From Acquisitions Markets are willing to value TFX stock at a premium because of the company's global growth ambitions. For example, NeoTract is another acquisition that will add 3% to the company's fourth-quarter revenue. With NeoTract's urology devices and Vascular Solutions adding positively to performance, Teleflex forecasts organic revenue growing 6% to 7% for the next three years (through to 2021). Growth in China is a notable achievement. While firms in the technology sector faced a slowing business in the region, Teleflex bucked the trend. Revenue expanded by around 14%, driven primarily by the decision to take the business direct in 2017. This led to higher sales volume. It stands to reason that if U.S.-China trade relations improve, Teleflex will benefit indirectly. ### 4 Levers to Sustain Growth Besides strategic mergers and acquisition activity, Teleflex has four ways to sustain and consistent growth. It's investing in key disease states, launching new products, growing utilization of its products, and leveraging its global infrastructure. If all of these catalysts play out, markets will treat TFX stock as a high-growth company, not just a medium-growth one. Investors have a single measure that differentiates Teleflex's growth: the rate of operating margin expansion. Teleflex has identified catheter complications, anesthesia, and percutaneous laparoscopy as a few key disease states and markets. In many ways, this market is immune to economic health because demand for the medical instruments will not change. * 7 Retail Stocks to Buy for the Rise of Menswear There's also a strong management team running Teleflex. It has a good track record of creating value from its acquisitions. Essential Medical and QT Vascular were its latest acquisitions, done in 2018. Still, the company faces external risks that are out of its control. Unfavorable exchange rates and tariffs on China resulted in operating margins getting trimmed very slightly. Once the U.S. and China reach a trade deal, Teleflex may raise its profit expectations for the next few years. ### Bottom Line on TFX Stock Analyst opinions are one way to get an idea of what Teleflex stock is worth. According to Tipranks, four analysts covering the stock have a price target of $310, implying an upside of 20%. The dearth of mainstream coverage on the company is potentially positive: not many investors will know about TFX stock. Conversely, its presentation at JP Morgan attracted many buyers, as trading volume topped 10 million shares recently. As of this writing, the author did not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Companies Apple Should Consider Buying * 7 Beaten-Up Housing Stocks Due for a Bounce Back * Take Buffett's Advice: 5 Vanguard Funds to Buy Compare Brokers The post Here's Why Markets Are Willing To Value Teleflex Stock At A Premium appeared first on InvestorPlace.
Teleflex Incorporated , a leading global provider of medical technologies with solutions in the fields of vascular and interventional access, surgical and cardiac care, will showcase the MANTA™ Vascular Closure Device as well as its portfolio for peripheral interventions at the Annual Meeting of the Leipzig Interventional Course 2019, in Leipzig, Germany.
Wildfires caused by PG&E Corporation (NYSE:PCG) appear to now consume PCG stock. This utility finds itself in trouble as its negligence led to numerous wildfires across northern California. As a result, PCG stock is now in freefall. In its descent, PCG has exhibited the one trait one never wants to see in a utility stock -- instability. ### RIP PCG Stock I usually think "opportunity" when I hear about instability in most stocks. I often see a scandal or a setback in an equity and think "buying opportunity." Events such as a big earnings miss, an unexpected CEO departure, a sex scandal, or the like often hit companies. Stockholders often react overreact to such occurrences, selling off a stock much more than the ensuing event justifies. InvestorPlace - Stock Market News, Stock Advice & Trading Tips The lows of the financial crisis serve as a great example. Investors who bought into the S&P 500 near its March 2009 low of 611 benefited from huge profits once the negative feelings abated. Not this time. * 7 Stocks to Buy as the Dollar Weakens PCG stock lost more than 40% of its value on Monday. After Monday, the freefall continued. Since early October, Pacific Gas & Electric stock has lost more than 85% of its value. Negligence by PG&E over poorly maintained power lines sparked wildfires causing billions in property damage. Sadly, many also perished in these fires. This will not go away with a few million in payoffs or a better earnings report in the next quarter. Given the magnitude of the financial damages PCG stock faces, bankruptcy remains its only viable option. As of this writing, PCG trades in the single digits and continues to fall. Another shoe dropped as the S&P Dow Jones Indices announced Teleflex (NYSE:TFX) would replace PCG stock in the S&P 500 on Jan. 18. ### Utility Stocks Require a Different Investor Mindset The issues go well beyond mere company negligence. The company also violated a rarely discussed assumption. PCG stock represents a utility. Nobody invests $5,000 in a utility in hopes of finding the next Amazon (NASDAQ:AMZN) and getting rich. Investors buy a utility stock to benefit from a stable, slow-growth equity that yields dividend income. More than that, investors expect these companies to define stability. These firms rarely face competition when they own the infrastructure. Their profit growth tends to mirror household formation increases and inflation. These firms often generate healthy dividends, but little else in the way of news. Peers such as NextEra Energy (NYSE:NEE), Duke Energy (NYSE:DUK) and Southern Company (NYSE:SO) quietly keep the power on, collect profits and pay dividends. If anything displaces a utility, one expects it would entail a technological shift such as the solar roof from Tesla (NASDAQ:TSLA). Few expect widespread negligence to take such a company down. However, PCG has become the exception. Looking back, the 2000 film Erin Brockovich should have served as a clue of the chronic issues that persist with PG&E. The negligence that caused the lawsuit discussed in that movie did nothing to change the company. As a result, PG&E faces another bankruptcy. Now, investors have to rethink whether the Warren Buffett mantra of "buy when there's blood in the streets" (or in California's case, when there's fire) should apply to utilities. * Top 10 Global Stock Ideas for 2019 From RBC Capital ### Final Thoughts on PCG Stock Due to its negligence, Pacific Gas & Electric reminded us that the instability we might tolerate from most equities has no place in a utility stock like PCG. More often than not, mistakes or unexpected setbacks create buying opportunities in stocks. However, with the essential role utilities play, instability can easily destroy such a company. This has become the case with PCG stock. Now, bankruptcy has become the company's only option. Bottom line, utilities should draw little attention. PCG stock broke that cardinal rule in the most outrageous manner imaginable. Now, bankruptcy courts will decide the fate of PG&E. It goes without saying that those who own this equity should get out before its lights out. More importantly, it reminds us that utility stocks should generate dividends, not attention. As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * Top 10 Global Stock Ideas for 2019 From RBC Capital * 10 A-Rated Stocks the Smart Money Is Piling Into * 5 Best Bank ETFs for This Week's Earnings Avalanche Compare Brokers The post The Fate of PG&E Stock Reminds Us to Treat Utilities Differently appeared first on InvestorPlace.
** Embattled power utility company PG&E Corp will be replaced by healthcare equipment maker Teleflex Inc in the S&P 500 on Friday ** PG&E shares were down 4.1 pct, trading near 2001 lows following its ...
will be replaced by S&P midcap constituent Teleflex Inc. in the S&P 500 on Friday, as PG&E has said it intends to file for bankruptcy amid lawsuits stemming from its role in the California wildfires in 2017 and 2018. Teleflex shares were down 2% in trading while PG&E shares fell 3.2%.
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced new data showing that both men and women have many misconceptions about benign prostatic hyperplasia (BPH) treatment options and side effects, as well as the impact of the condition on men’s overall health – suggesting that a focus on better understanding of this common condition may be in order for the new year. BPH, also known as enlarged prostate, is non-cancerous enlargement of the prostate that occurs as men age. “Data clearly show that both men and women have significant misconceptions about men’s health, including BPH and the ways to treat the condition,” said Ana Fadich, vice president of Men’s Health Network.
NEW YORK , Jan. 15, 2019 /PRNewswire/ -- S&P MidCap 400 constituent Teleflex Inc. (NYSE: TFX) will replace PG&E Corp. (NYSE: PCG) in the S&P 500, S&P SmallCap 600 constituent Green Dot Corp. (NYSE: GDOT) ...
Teleflex Inc. , a single-use medical devices company, will replace PG&E Corp. in the S&P 500 effective Jan. 18, the S&P Dow Jones Indices announced Tuesday. The changes come as PG&E indicated its intention to file for Chapter 11 bankruptcy later this month and is no longer eligible for inclusion in the large-cap index. Meanwhile, Green Dot Corp. , a personal finance company, will take Teleflex's spot in the S&P MidCap 400 while Mercer International Inc. will replace Green Dot in the S&P SmallCap 600 ahead of Friday's opening.
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...
NEW YORK, Jan. 07, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Liam Kelly, President and CEO, Teleflex Incorporated , is scheduled to speak at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California, on Tuesday, January 8, 2019 at 12:00 p.m.
For the second year in a row, Teleflex earned a top spot as a best place to work by US sales professionals in the annual MedReps.com Best Places to Work Survey. Teleflex Incorporated (TFX), a leading global provider of medical technologies for critical care and surgery, announced that it was named the winner of MedReps.com’s 8th Annual Best Places to Work 2019 survey for the Large Category Best Medical Device Companies and came in second in the Overall Category, covering Best Medical Device Companies, Best Pharma Companies and Best Biotech Companies. Positive culture, strong products and innovation, opportunities for growth, trustworthiness in their leaders and collaboration were among the top factors cited by survey participants when asked why a company should be named the best place to work.
In this article I am going to calculate the intrinsic value of Teleflex Incorporated (NYSE:TFX) by taking the expected future cash flows and discounting them to their present value. This Read More...